226 related articles for article (PubMed ID: 23972246)
1. Reporting standards for adverse events after medical device use in the peripheral vascular system.
Ouriel K; Fowl RJ; Davies MG; Forbes TL; Gambhir RP; Morales JP; Ricci MA;
J Vasc Surg; 2013 Sep; 58(3):776-86. PubMed ID: 23972246
[No Abstract] [Full Text] [Related]
2. [Non-interventional post-authorisation studies in Spain: justification and basis of a new regulation].
De La Fuente Honrubia C; De Abajo Iglesias FJ; García Del Pozo J; Vargas Castrillón E
Med Clin (Barc); 2010 May; 134(13):605-11. PubMed ID: 20304440
[No Abstract] [Full Text] [Related]
3. Ethics of private panels comes under scrutiny.
Wadman M
Nature; 1997 May; 387(6632):445. PubMed ID: 9168099
[No Abstract] [Full Text] [Related]
4. Pursuit of truly independent data monitoring committees in research.
Marston L; McKenzie DR; Freemantle N
BMJ; 2016 May; 353():i2309. PubMed ID: 27172924
[No Abstract] [Full Text] [Related]
5. Stopping guidelines for harm in a study designed to establish the safety of a marketed drug.
Fleishman AN; Parker RA
J Biopharm Stat; 2012; 22(2):338-50. PubMed ID: 22251178
[TBL] [Abstract][Full Text] [Related]
6. IRBs and monitoring the safety of clinical trials.
Maloney DM
Hum Res Rep; 2003 Jan; 18(1):3. PubMed ID: 12755095
[No Abstract] [Full Text] [Related]
7. Safety boards must report their conclusions to IRBs.
Maloney DM
Hum Res Rep; 1999 Oct; 14(10):3. PubMed ID: 11658061
[No Abstract] [Full Text] [Related]
8. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
Gordon VM; Sugarman J; Kass N
IRB; 1998; 20(1):1-5. PubMed ID: 11655324
[No Abstract] [Full Text] [Related]
9. Clinical evaluations clinical investigations under the amended Medical Device Directive.
Dannhorn DR; Schwabedissen H
Med Device Technol; 2008 Sep; 19(5):16-8, 20. PubMed ID: 18947145
[TBL] [Abstract][Full Text] [Related]
10. How should adverse events be reported in US clinical trials?: ethical considerations.
Shamoo AE; Katzel LI
Clin Pharmacol Ther; 2008 Aug; 84(2):275-8. PubMed ID: 18305454
[TBL] [Abstract][Full Text] [Related]
11. The IRB is not a data and safety monitoring board.
Bankert E; Amdur R
IRB; 2000; 22(6):9-11. PubMed ID: 11883486
[No Abstract] [Full Text] [Related]
12. Data monitoring committees for pragmatic clinical trials.
Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
[TBL] [Abstract][Full Text] [Related]
13. Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials.
Nedeltchev K; Pattynama PM; Biaminoo G; Diehm N; Jaff MR; Hopkins LN; Ramee S; van Sambeek M; Talen A; Vermassen F; Cremonesi A;
Catheter Cardiovasc Interv; 2010 Sep; 76(3):333-44. PubMed ID: 20506555
[TBL] [Abstract][Full Text] [Related]
14. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
Tuffs A
BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
[No Abstract] [Full Text] [Related]
15. Application of the Consolidated Standards of Reporting Trials (CONSORT) in the Fracture Care Literature.
Bhandari M; Guyatt GH; Lochner H; Sprague S; Tornetta P
J Bone Joint Surg Am; 2002 Mar; 84(3):485-9. PubMed ID: 11886922
[No Abstract] [Full Text] [Related]
16. Interpreting and reporting clinical trials with results of borderline significance.
Hackshaw A; Kirkwood A
BMJ; 2011 Jul; 343():d3340. PubMed ID: 21727163
[No Abstract] [Full Text] [Related]
17. EU and US clinical investigation adverse event reporting.
Crowley G
Med Device Technol; 2004 Jun; 15(5):30-2. PubMed ID: 15285486
[TBL] [Abstract][Full Text] [Related]
18. Reporting problems in human research and resultant investigations by IRBs.
Maloney DM
Hum Res Rep; 2002 Aug; 17(8):6-7. PubMed ID: 12731495
[No Abstract] [Full Text] [Related]
19. The European "clinical trial" regulation; relationship with the Jardé Act: a Giens workshop.
Lemaire F; Marchenay B; Chassany O; ; Barthélémy P; Bouzzagou M; Comet D; Delval C; Dubray C; Fouret C; Frija-Orvoen E; Gambotti L; Lamarque V; d'Orsay G; Plattner V; Sibenaler C; Roux J; Thoby F
Therapie; 2015; 70(1):21-36. PubMed ID: 25679191
[TBL] [Abstract][Full Text] [Related]
20. Improving protection for research subjects.
Steinbrook R
N Engl J Med; 2002 May; 346(18):1425-30. PubMed ID: 11986426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
